Proceedings.

Origin Biomed Inc.

Follow
Active
Proceeding
Receivership (court-appointed)section 243(1) of the Bankruptcy and Insolvency Act
File
Hfx. No. 437782
Filings held3
Last activity4 Jun 2015
On the record4,185 days
Secured debtSubscribers
OverviewSummary updated

Origin Biomed Inc. has been under court-appointed receivership since April 7, 2015, when the Supreme Court of Nova Scotia (In Bankruptcy & Insolvency) appointed Grant Thornton Limited receiver and manager under section 243(1) of the Bankruptcy and Insolvency Act on the application of Knight Therapeutics Inc., in Hfx. No. 437782. Knight Therapeutics holds security over substantially all of the company's present and after-acquired personal property, excluding accounts, monies and deposits secured to Toronto-Dominion Bank, and had obligations owing of $2,396,616.17 as of February 24, 2015, with interest and realization costs continuing to accrue; it has given notice under section 62 of the PPSA to take the collateral in satisfaction. Roynat Inc. holds equipment security over copiers and printers, and Bionica Inc. holds security tied to the 'Bionica' gel cream product, including inventory, intellectual property and trademarks, which Bionica's solicitor advised relates only to Bionica products. The receiver advised there were no deposits at TD Bank as of May 31, 2015. The proceeding remains active.

Proceedings AIAsk this case — answers cite the filings
Ask in plain language. The answer comes only from this case’s filings, each one cited.
Enter to send · Shift+Enter for a new line
Case updates3 dated entries
#Filing

Application filed June 1, 2015, commencing the court-appointed receivership proceedings before the Supreme Court of Nova Scotia in Bankruptcy and Insolvency, file Hfx. No. 437782.

Source: Notice of Motion dated June 1, 2015

#Order

Court appointed Grant Thornton Limited receiver and manager of Origin Biomed Inc. under s. 243(1) of the BIA, on Knight Therapeutics Inc.'s application.

Source: Order Appointing the Receiver

Parties

Debtor

Origin Biomed Inc.

Receiver

Doane Grant Thornton

Capital structureAs asserted in the filings
Priority classCreditorAmountSource
SecuredKnight Therapeutics Inc. (KTI)All present and after-acquired personal property (equipment, inventory, accounts, documents of title, chattel paper, IP, licenses, etc.), excluding present accounts/monies/deposits secured to TD Bank — Related party is the moving plaintiff/secured creditor giving notice under s.62 PPSA to take collateral in satisfaction; obligations totaled $2,396,616.17 as of Feb 24, 2015 with interest and realization costs continuing to accrue — debtor: Origin Biomed Inc. · as of 24 Feb 2015$2.4MNotice of Motion dated June 1, 2015

This proceeding was commenced by a secured creditor. The record does not include the debtor’s own statement of assets and liabilities — that ceiling is the record’s, not this page’s.

3 more claims across lower-ranking classes

Subscribe

Already a subscriber? Sign in.

Documents3 filings
DateDocumentFile
Order for DirectionsPDF · Subscribers
Notice of Motion dated June 1, 2015
  • Applicant Grant Thornton Limited
  • Commencement date 1 June 2015
  • Court SUPREME COURT OF NOVA SCOTIA
  • Court file no Hfx. No. 437782
  • + 4 more extracted facts
PDF · Subscribers
Order Appointing the Receiver
  • Applicant Knight Therapeutics Inc.
  • Appointee Grant Thornton Limited
  • Appointee role receiver and manager
  • Commencement date 7 April 2015
  • + 3 more extracted facts
PDF · Subscribers

Filing titles and dates are public, and so is each filing's own page. The figures read from them are for subscribers.

CiteProceedings., “Origin Biomed Inc.” (Receivership (court-appointed)), Supreme Court of Nova Scotia. Retrieved 20 September 2026, https://proceedings.ca/case/origin-biomed-inc

Sources last checked · summary updated 19 August 2026 · Report a correction · Printed from proceedings.ca/case/origin-biomed-inc

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.